English
中文繁體
中文简体

Dark
Light

Open Account

HK Stock MarketDetailed Quotes

01801 INNOVENT BIO

Watchlist

53.650
-0.550-1.01%

Not Open Apr 29 16:08 CST

88.42BMarket Cap-865.32P/E (TTM)

INNOVENT BIO Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:CNY

2024/FY

Stock NameRevenueRatio

Pharmaceutical product sales8.23B87.33%

Authorization fee income1.1B11.68%

Income from R & D service charges93.78M1.00%

Product Currency:CNY

2024/FY

Stock NameRevenueRatio

Pharmaceutical product sales8.23B87.33%

Authorization fee income1.1B11.68%

Income from R & D service charges93.78M1.00%

Region Currency:CNY

2024/FY

Stock NameRevenueRatio

China8.98B95.35%

United States of America.411.59M4.37%

Other26.88M0.29%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.